Literature DB >> 7647001

Expression of erythroid-specific genes in acute megakaryoblastic leukaemia and transient myeloproliferative disorder in Down's syndrome.

E Ito1, M Kasai, Y Hayashi, T Toki, K Arai, S Yokoyama, K Kato, N Tachibana, M Yamamoto, M Yokoyama.   

Abstract

Acute megakaryoblastic leukaemia (M7) and transient myeloproliferative disorder in Down's syndrome (TMD) are characterized by rapid growth of abnormal blast cells which express megakaryocytic markers. To clarify properties of the blast cells in M7 and TMD cases, we examined erythroid markers expression in blasts from six cases with M7 and seven cases with TMD in this study. Erythroid-specific mRNAs encoding gamma-globin and erythroid delta-aminolevulinate synthase were found to be expressed in blasts from most of these cases, indicating that majorities of the blasts in M7 and TMD cases have erythroid and megakaryocytic phenotypes. We also found that mRNAs encoding GATA-1 and GATA-2 are expressed in all these cases. These results suggest that M7 blasts and TMD blasts correspond to the erythroid/megakaryocytic bipotential progenitor cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7647001     DOI: 10.1111/j.1365-2141.1995.tb05591.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

1.  Identification of CD13+CD36+ cells as a common progenitor for erythroid and myeloid lineages in human bone marrow.

Authors:  Ling Chen; Zhigang Gao; Jianqiong Zhu; Griffin P Rodgers
Journal:  Exp Hematol       Date:  2007-07       Impact factor: 3.084

Review 2.  Myeloid leukemia in Down syndrome.

Authors:  Irum Khan; Sébastien Malinge; John Crispino
Journal:  Crit Rev Oncog       Date:  2011

3.  Trisomy 21 enhances human fetal erythro-megakaryocytic development.

Authors:  Stella T Chou; Joanna B Opalinska; Yu Yao; Myriam A Fernandes; Anna Kalota; John S J Brooks; John K Choi; Alan M Gewirtz; Gwenn-ael Danet-Desnoyers; Richard L Nemiroff; Mitchell J Weiss
Journal:  Blood       Date:  2008-09-23       Impact factor: 22.113

4.  Cross-talk of GATA-1 and P-TEFb in megakaryocyte differentiation.

Authors:  Kamaleldin E Elagib; Ivailo S Mihaylov; Lorrie L Delehanty; Grant C Bullock; Kevin D Ouma; Jill F Caronia; Sara L Gonias; Adam N Goldfarb
Journal:  Blood       Date:  2008-09-09       Impact factor: 22.113

5.  Developmental differences in IFN signaling affect GATA1s-induced megakaryocyte hyperproliferation.

Authors:  Andrew J Woo; Karen Wieland; Hui Huang; Thomas E Akie; Taylor Piers; Jonghwan Kim; Alan B Cantor
Journal:  J Clin Invest       Date:  2013-07-01       Impact factor: 14.808

6.  ETS2 and ERG promote megakaryopoiesis and synergize with alterations in GATA-1 to immortalize hematopoietic progenitor cells.

Authors:  Monika J Stankiewicz; John D Crispino
Journal:  Blood       Date:  2009-01-23       Impact factor: 22.113

7.  MicroRNA-486-5p is an erythroid oncomiR of the myeloid leukemias of Down syndrome.

Authors:  Lital Shaham; Elena Vendramini; Yubin Ge; Yaron Goren; Yehudit Birger; Marloes R Tijssen; Maureen McNulty; Ifat Geron; Omer Schwartzman; Liat Goldberg; Stella T Chou; Holly Pitman; Mitchell J Weiss; Shulamit Michaeli; Benjamin Sredni; Berthold Göttgens; John D Crispino; Jeffrey W Taub; Shai Izraeli
Journal:  Blood       Date:  2014-12-22       Impact factor: 22.113

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.